255
Participants
Start Date
November 11, 2019
Primary Completion Date
December 31, 2020
Study Completion Date
January 30, 2021
Benzimidazole Anthelmintic
The participants diagnosed positive will be randomly assigned to one of the following treatment arms of the study. Parents or guardians of eligible children will be asked to bring them to the CERMEL (clinic). after a brief clinical examination child fulfilling inclusion criteria will be randomly assigned to one of the following treatment regimens of the study.
Centre de Recherches Médicales de Lammbaréné, Lambaréné
Centre de Recherche Médicale de Lambaréné
OTHER